Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed October 2026Updated October 2026

Ovagen Dosing Protocol: 20 mg Vial, Reconstitution & Units

Ovagen (Glu-Asp-Leu tripeptide) bioregulator: community-reported dosing, reconstitution math, and what the research does and doesn't support.

Quickstart highlights

Ovagen is the synthetic tripeptide Glu-Asp-Leu (EDL, coded T-35 in some studies) from Vladimir Khavinson's bioregulator program in St.

  • No human dose has been established. Every amount on this page is community-reported, not from a trial.
  • 200 µg once daily for 10 days is the commonly discussed community schedule.
  • 20 mg vial + 10 mL bac water = 2 mg/mL, so 200 µg = 0.1 mL = 10 units.
  • One 20 mg vial holds 100 doses of 200 µg, but if you follow the 28-day use window most of a vial is left after one 10-day course.
  • Ovagen's published research is on the kidney in rats and cell cultures. See the Ovagen peptide page for the evidence.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-2 (10-day course)20010Once dailyCommunity-reported, not from a trial; 200 µg = 10 units at 2 mg/mL; one 20 mg vial holds 100 doses
Maintenance20010Every other dayCommunity-reported, not from a trial; no study has tested a maintenance schedule

Your free Ovagen tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Add 10 mL bacteriostatic water in total to the 20 mg vial, running it slowly down the vial wall. Check first that your vial can hold 10 mL.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: 2 mg/mL. On a U-100 insulin syringe, 200 µg = 0.1 mL = 10 units.
  4. Label with the date; refrigerate at 2–8 °C and use within 28 days.

Supplies needed

10_day-week plan

  • 1 vial
  • 10 syringes
  • 10 mL bac water
  • 10 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reference schedule and reconstitution math for a 20 mg Ovagen vial. Ovagen's published research is rat kidney studies and kidney cell cultures, with no human trials, so every dose on this page is community-reported, not clinically established.

Off-cycle: Not established. Community sources describe 4–6 months between courses; no study has tested cycle length.

Storage & handling

Lyophilized: store below 25 °C, away from light. Reconstituted: refrigerate at 2–8 °C and use within 28 days.

Injection & tracking tips

  • Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing.
  • Rotate injection sites and use a new sterile syringe every time.
  • No study has tested Ovagen combined with BPC-157 or any other peptide, so combination protocols are untested.
  • Ovagen has no human safety data. In rats it changed urine output and sodium excretion, so if you have kidney disease or take diuretics or blood pressure medicines, keep your physician involved.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • If your physician orders kidney tests (creatinine, eGFR), note the dates relative to each course.
  • Log any medication changes during and after each course.
  • Record any injection-site reactions or other symptoms, with dates.
Log your cycle in the calculator →

How this works & references

Ovagen is the synthetic tripeptide Glu-Asp-Leu (EDL, coded T-35 in some studies) from Vladimir Khavinson's bioregulator program in St. Petersburg. In aging kidney cell cultures it lowered the aging markers p16, p21 and p53 and raised SIRT6; in rats with cisplatin, gentamicin or ischemic kidney injury it reduced protein loss in urine and preserved urine output. Vendors sell it for the liver and gut, but no published study has tested those uses. There are no human trials, and the research has not been independently replicated.

Frequently asked questions

What is the Ovagen peptide dosage?
There is no established Ovagen dosage, because no human trial has tested one, and the rat study abstracts do not report the doses used. The schedule on this page, 200 µg once daily for 10 days, is commonly discussed but unverified.
How is Ovagen injected?
Research vials are sold as a powder to be mixed with bacteriostatic water, and community protocols inject it under the skin. No study has tested injected Ovagen in people, so there is no data on absorption, timing or the best site.
What is Ovagen peptide used for?
Vendors market it for the liver and the digestive tract. The published studies of Glu-Asp-Leu are almost all on the kidney: rat models of drug-induced and ischemic kidney injury, old rats, and aging kidney cell cultures. We found no published study of Ovagen for liver or gut health.
What are the benefits of Ovagen peptide?
In rats with kidney injury, it reduced protein loss in urine, preserved urine output and supported antioxidant enzymes in kidney tissue. In aging kidney cell cultures it lowered aging markers. Whether any of this happens in people is unknown.
Is Ovagen the same as R18 Ovagen or the veterinary Ovagen?
No. R18 Ovagen is a homeopathic drop with different ingredients, and the Ovagen in veterinary research is a sheep FSH hormone used for embryo transfer in goats and sheep. Neither is related to the Glu-Asp-Leu peptide.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.